This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1992:312:95-109.

doi: 10.1007/978-1-4615-3462-4_9.

Catalytic antisense RNA (ribozymes): their potential and use as anti-HIV-1 therapeutic agents

J J Rossi¹, N Sarver

Affiliations

PMID: 1514448
DOI: 10.1007/978-1-4615-3462-4_9

Review

Catalytic antisense RNA (ribozymes): their potential and use as anti-HIV-1 therapeutic agents

J J Rossi et al. Adv Exp Med Biol. 1992.

. 1992:312:95-109.

doi: 10.1007/978-1-4615-3462-4_9.

Authors

J J Rossi¹, N Sarver

Affiliation

¹ Department of Molecular Genetics, Beckman Research Institute of the City of Hope, Duarte, CA 91010.

PMID: 1514448
DOI: 10.1007/978-1-4615-3462-4_9

No abstract available

PubMed Disclaimer

Similar articles

Exploring the use of antisense, enzymatic RNA molecules (ribozymes) as therapeutic agents.
Rossi JJ, Elkins D, Taylor N, Zaia J, Sullivan S, Deshler JO. Rossi JJ, et al. Antisense Res Dev. 1991 Fall;1(3):285-8. Antisense Res Dev. 1991. PMID: 1821650 Review.
Gene therapeutic agents: the use of ribozymes, antisense, and RNA decoys for HIV-1 infection.
Smythe JA, Symonds G. Smythe JA, et al. Inflamm Res. 1995 Jan;44(1):11-5. doi: 10.1007/BF01630480. Inflamm Res. 1995. PMID: 7664023 Review. No abstract available.
Therapeutic applications of catalytic antisense RNAs (ribozymes).
Rossi JJ. Rossi JJ. Ciba Found Symp. 1997;209:195-204; discussion 204-6. doi: 10.1002/9780470515396.ch14. Ciba Found Symp. 1997. PMID: 9383577 Review.
RNA enzymes (ribozymes) as antiviral therapeutic agents.
Rossi JJ, Sarver N. Rossi JJ, et al. Trends Biotechnol. 1990 Jul;8(7):179-83. doi: 10.1016/0167-7799(90)90169-x. Trends Biotechnol. 1990. PMID: 1366622 Review.
Status of ribozyme and antisense-based developmental approaches for anti-HIV-1 therapy.
Zaia JA, Chatterjee S, Wong KK, Elkins D, Taylor NR, Rossi JJ. Zaia JA, et al. Ann N Y Acad Sci. 1992 Oct 28;660:95-106. doi: 10.1111/j.1749-6632.1992.tb21062.x. Ann N Y Acad Sci. 1992. PMID: 1340161 Review. No abstract available.

See all similar articles

Cited by

Activation of HIV-specific ribozyme activity by self-cleavage.
Ventura M, Wang P, Ragot T, Perricaudet M, Saragosti S. Ventura M, et al. Nucleic Acids Res. 1993 Jul 11;21(14):3249-55. doi: 10.1093/nar/21.14.3249. Nucleic Acids Res. 1993. PMID: 8341599 Free PMC article.
Inhibition of HPV-16 E6/E7 immortalization of normal keratinocytes by hairpin ribozymes.
Alvarez-Salas LM, Cullinan AE, Siwkowski A, Hampel A, DiPaolo JA. Alvarez-Salas LM, et al. Proc Natl Acad Sci U S A. 1998 Feb 3;95(3):1189-94. doi: 10.1073/pnas.95.3.1189. Proc Natl Acad Sci U S A. 1998. PMID: 9448307 Free PMC article.
Multidimensional futuristic approaches to address the pandemics beyond COVID-19.
Kotwal SB, Orekondey N, Saradadevi GP, Priyadarshini N, Puppala NV, Bhushan M, Motamarry S, Kumar R, Mohannath G, Dey RJ. Kotwal SB, et al. Heliyon. 2023 Jun;9(6):e17148. doi: 10.1016/j.heliyon.2023.e17148. Epub 2023 Jun 11. Heliyon. 2023. PMID: 37325452 Free PMC article. Review.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

Grants and funding

LinkOut - more resources

Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information